Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Novartis ag crawled time : 12:20 save search
Precision BioSciences Reports Second Quarter 2023 Financial Results and Provides Business Update
Published: 2023-08-04 (Crawled : 12:20) - precisionbiosciences.com
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.38%
H: 0.73%
C: 0.15%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.53%
H: 0.0%
C: 0.0%
DTIL | $9.75 -9.05% -9.95% 170K
|
Health Technology
|
| O: -0.95%
H: 0.0%
C: 0.0%
business update financial results
Novartis strengthens commitment to Beacon of Hope initiative, engages new collaborators to support clinical trial diversity, break down economic and education barriers
Published: 2023-07-12 (Crawled : 12:20) - biospace.com/
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.29%
H: 0.49%
C: 0.26%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.89%
H: 0.0%
C: 0.0%
hope beacon education novartis trial
Mammography Market is expected to display a steady growth of 8% due to the rise in research and development activities| UnivDatos Market Insights
Published: 2023-03-02 (Crawled : 12:20) - prnewswire.com
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.23%
H: 1.48%
C: 1.32%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: -0.19%
H: 0.72%
C: -0.06%
HOLX | $75.37 0.36% 0.36% 1.3M
|
Health Technology
|
| O: -0.52%
H: 1.89%
C: 1.82%
EXEL | $22.51 0.09% 0.09% 2.3M
|
Health Technology
|
| O: -0.52%
H: 0.23%
C: -1.15%
research expected growth market
Retinal drugs market size to increase by USD 7.27579 billion; North America to account for 42% of market growth - Technavio
Published: 2023-02-08 (Crawled : 12:20) - prnewswire.com
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.72%
H: 0.52%
C: -0.08%
ALC | $79.55 1.38% -0.25% 1.1M
|
Health Technology
|
| O: 0.28%
H: 0.21%
C: -0.41%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.19%
H: 0.65%
C: -0.55%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 3.05%
H: 0.0%
C: 0.0%
MGTX | $5.09 1.6% 1.57% 190K
|
Health Technology
|
| O: -1.14%
H: 4.62%
C: -0.77%
america growth market
Lipid Based Formulations Global Market Report 2023: Featuring Novartis, AbbVie, F. Hoffmann-La Roche, Johnson & Johnson, Alnylam Pharmaceuticals & More
Published: 2023-01-27 (Crawled : 12:20) - prnewswire.com
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.56%
H: 0.73%
C: 0.17%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.21%
H: 0.19%
C: -0.18%
pharmaceuticals global report market
Alzheimer’s Therapeutics market is projected to grow at a CAGR of 9.17% by 2032: Visiongain Reports Ltd
Published: 2022-12-13 (Crawled : 12:20) - biospace.com/
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 1.34%
H: 0.0%
C: 0.0%
VTRS A | $11.25 1.17% 1.16% 4.7M
|
Health Technology
|
| O: 1.89%
H: 0.88%
C: -0.09%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 1.28%
H: 0.2%
C: -0.9%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.71%
H: 0.61%
C: 0.06%
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: 1.09%
H: 0.32%
C: -0.85%
therapeutics alzheimer’s market
REGENXBIO Reports Third Quarter 2022 Financial Results and Recent Operational Highlights
Published: 2022-11-03 (Crawled : 12:20) - biospace.com/
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.82%
H: 0.83%
C: 0.56%
QURE | $4.68 -0.64% -0.64% 550K
|
Health Technology
|
| O: -2.13%
H: 4.15%
C: -0.56%
RARE | News F | $42.37 -2.33% -2.38% 680K
|
Health Technology
|
| O: 0.25%
H: 3.17%
C: -6.19%
RCKT M | $22.82 -2.81% -2.89% 960K
|
Health Technology
|
| O: -1.88%
H: 4.96%
C: 0.17%
RGNX | $15.67 -2.73% -2.87% 570K
|
Health Technology
|
| O: -3.01%
H: 0.77%
C: -10.46%
financial results
Baxter Reports Second-Quarter 2022 Results
Published: 2022-07-28 (Crawled : 12:20) - biospace.com/
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -0.12%
H: 2.36%
C: 2.36%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.02%
H: 0.99%
C: 0.56%
BAX | $39.47 -0.45% 0.0% 2.8M
|
Health Technology
|
| O: -7.56%
H: 1.47%
C: -3.64%
results
Valued to be $12.9 Billion by 2026, Crohn`s Disease (CD) Therapy Slated for Robust Growth Worldwide
Published: 2022-06-27 (Crawled : 12:20) - prnewswire.com
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: -1.55%
H: 4.43%
C: 0.03%
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 1.46%
H: 1.45%
C: 0.78%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 0.72%
H: 0.0%
C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 1.86%
H: 1.05%
C: 0.24%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.78%
H: 0.94%
C: 0.26%
CCXI | $51.99 -0.04%
|
Health Technology
|
| O: -4.88%
H: 1.04%
C: -1.25%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -0.36%
H: 1.22%
C: 0.38%
disease therapy growth
Global High Potency Active Pharmaceutical Ingredient (HPAPI) Market Report 2022 with Competitive Landscape Analysis of Eli Lily and Co; Novartis; Bristol-Myers Squibb; Roche Diagnostics; Sanofi
Published: 2022-06-17 (Crawled : 12:20) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 0.01%
H: 0.17%
C: 0.17%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.76%
H: 5.75%
C: 5.5%
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: 1.89%
H: 0.0%
C: -0.64%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.74%
H: 0.52%
C: -3.23%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.07%
H: 0.0%
C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.24%
H: 0.0%
C: 0.0%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 0.57%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.39%
H: 0.0%
C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 0.59%
H: 0.0%
C: 0.0%
active report roche sanofi market diagnostic
Novartis five-year Kymriah® data show durable remission and long-term survival maintained in children and young adults with advanced B-cell ALL
Published: 2022-06-12 (Crawled : 12:20) - globenewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
| Email alert
Add to watchlist
kymriah children novartis
Novartis Tafinlar® (dabrafenib) + Mekinist® (trametinib) demonstrates unprecedented efficacy in pediatric patients with BRAF V600 low-grade gliomas in Phase II/III study
Published: 2022-06-06 (Crawled : 12:20) - prnewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -1.87%
H: 2.91%
C: 2.91%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.31%
H: 0.0%
C: -1.04%
tafinlar novartis
Novartis receives positive CHMP opinion for Kymriah® CAR-T cell therapy for adult patients with relapsed or refractory follicular lymphoma in Europe
Published: 2022-03-25 (Crawled : 12:20) - globenewswire.com
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 1.14%
H: 0.0%
C: 0.0%
kymriah novartis europe car-t positive therapy chmp t-cell
Novartis receives positive CHMP opinion for Jakavi® to treat acute and chronic graft-versus-host disease
Published: 2022-03-25 (Crawled : 12:20) - globenewswire.com
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 1.14%
H: 0.0%
C: 0.0%
jakavi novartis disease positive chmp
Novartis announces iptacopan met Phase II study primary endpoint in rare kidney disease IgA nephropathy (IgAN)
Published: 2021-06-06 (Crawled : 12:20) - globenewswire.com
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
| Email alert
Add to watchlist
disease nephropathy kidney rare igan
Novartis Phase III Beovu® data show potential for fluid resolution in more diabetic macular edema patients with fewer injections versus aflibercept
Published: 2021-05-01 (Crawled : 12:20) - globenewswire.com
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
| Email alert
Add to watchlist
potential injection macular diabetic diabetes
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.